{
    "2018-03-16": [
        [
            {
                "time": "",
                "original_text": "康泰生物今日大宗交易成交50万股，成交价49.5元折价8.16%",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "大宗交易",
                        "成交价",
                        "折价"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "康泰生物：直销渠道的成熟 销售费用有望下降",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "直销渠道",
                        "销售费用",
                        "下降"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "康泰生物：公司四联苗增长可期，重磅产品将陆续上市",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "四联苗",
                        "增长",
                        "重磅产品",
                        "上市"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药股“闷声发财”擒消费升级方得奇兵",
                "features": {
                    "keywords": [
                        "医药股",
                        "消费升级"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业:看好创新药与一致性评价领域龙头白马",
                "features": {
                    "keywords": [
                        "医药生物",
                        "创新药",
                        "一致性评价",
                        "龙头",
                        "白马"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}